A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
August 06, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Second Quarter 2021 Financial Results
August 05, 2021 16:01 ET | electroCore, Inc.
ROCKAWAY, NJ, Aug. 05, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced second quarter 2021 financial results and provided an...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial
August 04, 2021 09:25 ET | Odyssey Group International
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Publication in PharmacoEconomics Reiterating Economic Benefits of gammaCore for Cluster Headache Outlined by The National Institute for Health and Care Excellence (NICE) Medical Technologies Guidance
August 04, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Aug. 04, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company (the Company), today announced the release of an article entitled...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Present at the Canaccord Genuity Growth Conference
August 02, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, Aug. 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
A743C747-1A0E-411A-BE19-027558A02AB3.png
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield”  to Discuss Concussion Treatments
July 27, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, July 27, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
July 27, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, July 27, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
July 26, 2021 08:32 ET | Odyssey Group International
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th
July 22, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, July 22, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience
July 19, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief...